Comparative test on the occurrence rate of side effects accompanying duloxetine oral dosing timing

Comparative test on the occurrence rate of side effects accompanying duloxetine oral dosing timing - Study on the incidence of adverse reactions due to internal timing of duloxetine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026441

Enrollment

Registered

2017-04-15

Start date

2017-03-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic pain

Interventions

Oral intake of duloxetine after breakfast Oral intake of duloxetine befor sleep

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Patients with pain of 1 month or more 2 Patients over 26 years of age 3 Document consent has been obtained from the patient himself or his substitute.

Exclusion criteria

Exclusion criteria: 1 Patients under 25 years of age 2 A patient with suicide ideas and suicide attempts in the past 3 Patients with a history of hypersensitivity to the ingredients of this drug 4 Patients during monoamine oxidase inhibitor administration or within 2 weeks after discontinuation of administration 5 Patients with high liver damage or advanced renal impairment 6 Patient with poor control of closed angle glaucoma

Design outcomes

Primary

Measure	Time frame
Presence or absence of side effects within 4 weeks after starting oral administration	—

Countries

Japan

Contacts

Public ContactMiyuki Niimi

Saku Central Hospital Clinical research and study center

ctroffice@sakuhp.or.jp0267823131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026